Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TBI, Cyclophosphamide, Fludarabine, and Alternate Donor HCT in Fanconi's Anemia
NCT00005898Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Feb 2000
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin rabbit, cyclophosphamide, fludarabine in Fanconi anemia (FA), sponsored by University of Minnesota. Started Feb 2000; status: completed.
02
Drugs
antithymocyte globulin rabbitcyclophosphamidefludarabine
03
Conditions
Fanconi anemia (FA)
Beyond the preview
Go deeper on NCT00005898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005898.